Literature DB >> 22290423

Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China.

Mingming Jia1, Kunxue Hong, Jianping Chen, Yuhua Ruan, Zhe Wang, Bing Su, Guoliang Ren, Xiaoqing Zhang, Zhen Liu, Quanbi Zhao, Dan Li, Hong Peng, Marcus Altfeld, Bruce D Walker, Xu G Yu, Yiming Shao.   

Abstract

It is generally believed that CD8(+) cytotoxic T lymphocytes (CTLs) play a critical role in limiting the replication of human immunodeficiency virus type 1 (HIV-1) and in determining the outcome of the infection, and this effect may partly depend on which HIV product is preferentially targeted. To address the correlation between HIV-1-specific CTL responses and virus replication in a cohort of former plasma donors (FPDs), 143 antiretroviral therapy naive FPDs infected with HIV-1 clade B' strains were assessed for HIV-1-specific CTL responses with an IFN-γ Elispot assay at single peptide level by using overlapping peptides (OLPs) covering the whole consensus clade B proteome. By using a Spearman's rank correlation analysis, we found that the proportion of Gag-specific CTL responses among the total virus-specific CTL activity was inversely correlated with viral loads while being positively correlated to CD4 counts, as opposed to Pol- and Env-specific responses that were associated with increased viral loads and decreased CD4 counts. In addition, Vpr-specifc CTL responses showed a similar protective effect with Gag responses, but with a much lower frequency of recognition. Significantly, we also observed an association between HLA-A*30/B*13/Cw*06 haplotype and lower viral loads that was probably due to restricted Gag-specific CTL responses. Thus, our data demonstrate the prominent role of Gag-specific CTL responses in disease control. The advantage of HLA-A*30/B*13/Cw*06 haplotype in viral control may be associated with the contribution of Gag-specific CTL responses in the studied individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290423      PMCID: PMC3343654          DOI: 10.1038/cr.2012.19

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  45 in total

1.  Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.

Authors:  Jaclyn K Wright; Vladimir Novitsky; Mark A Brockman; Zabrina L Brumme; Chanson J Brumme; Jonathan M Carlson; David Heckerman; Bingxia Wang; Elena Losina; Mopo Leshwedi; Mary van der Stok; Lungile Maphumulo; Nompumelelo Mkhwanazi; Fundisiwe Chonco; Philip J R Goulder; Max Essex; Bruce D Walker; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

Review 3.  HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr).

Authors:  Biswanath Majumder; Narasimhan J Venkatachari; Alagarsamy Srinivasan; Velpandi Ayyavoo
Journal:  Curr HIV Res       Date:  2009-03       Impact factor: 1.581

4.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.

Authors:  Rachel E Owen; John W Heitman; Dale F Hirschkorn; Marion C Lanteri; Hope H Biswas; Jeffrey N Martin; Melissa R Krone; Steven G Deeks; Philip J Norris
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

7.  Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.

Authors:  Bradley H Edwards; Anju Bansal; Steffanie Sabbaj; Janna Bakari; Mark J Mulligan; Paul A Goepfert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.

Authors:  Toshiyuki Miura; Mark A Brockman; Arne Schneidewind; Michael Lobritz; Florencia Pereyra; Almas Rathod; Brian L Block; Zabrina L Brumme; Chanson J Brumme; Brett Baker; Alissa C Rothchild; Bin Li; Alicja Trocha; Emily Cutrell; Nicole Frahm; Christian Brander; Ildiko Toth; Eric J Arts; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

Review 9.  PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.

Authors:  Daniel E Kaufmann; Bruce D Walker
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

Authors:  Arne Schneidewind; Mark A Brockman; Ruifeng Yang; Rahma I Adam; Bin Li; Sylvie Le Gall; Charles R Rinaldo; Sharon L Craggs; Rachel L Allgaier; Karen A Power; Thomas Kuntzen; Chang-Shung Tung; Montiago X LaBute; Sandra M Mueller; Thomas Harrer; Andrew J McMichael; Philip J R Goulder; Christopher Aiken; Christian Brander; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

View more
  11 in total

1.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

2.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.

Authors:  Dariusz K Murakowski; John P Barton; Lauren Peter; Abishek Chandrashekar; Esther Bondzie; Ang Gao; Dan H Barouch; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

4.  Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.

Authors:  Aniqa Shahid; Alex Olvera; Gursev Anmole; Xiaomei T Kuang; Laura A Cotton; Montserrat Plana; Christian Brander; Mark A Brockman; Zabrina L Brumme
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

5.  Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.

Authors:  M Jia; D Li; X He; Y Zhao; H Peng; P Ma; K Hong; H Liang; Y Shao
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

6.  Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.

Authors:  Matilda Chelimo Saina; Xiuqiong Bi; Raphael Lihana; Raphael Lwembe; Azumi Ishizaki; Annie Panikulam; Tresa Palakudy; Rachel Musoke; Mary Owens; Elijah Maritim Songok; Hiroshi Ichimura
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

7.  Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.

Authors:  Zejun Wei; Yang Liu; Heng Xu; Kun Tang; Hao Wu; Lin Lu; Zhe Wang; Zhengjie Chen; Junjie Xu; Yufei Zhu; Landian Hu; Hong Shang; Guoping Zhao; Xiangyin Kong
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

Review 8.  Plant-based vaccines against viruses.

Authors:  Edward P Rybicki
Journal:  Virol J       Date:  2014-12-03       Impact factor: 4.099

9.  The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells.

Authors:  Gabriel Duette; Bonnie Hiener; Hannah Morgan; Fernando G Mazur; Vennila Mathivanan; Bethany A Horsburgh; Katie Fisher; Orion Tong; Eunok Lee; Haelee Ahn; Ansari Shaik; Rémi Fromentin; Rebecca Hoh; Charline Bacchus-Souffan; Najla Nasr; Anthony L Cunningham; Peter W Hunt; Nicolas Chomont; Stuart G Turville; Steven G Deeks; Anthony D Kelleher; Timothy E Schlub; Sarah Palmer
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 14.808

10.  Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A*30-B*13-C*06-positive patients.

Authors:  Hui Zhang; Xiaoxu Han; Bin Zhao; Minghui An; Zhe Wang; Fanming Jiang; Junjie Xu; Zining Zhang; Tao Dong; Hong Shang
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.